Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5510383A · kind A · utility
62Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 3, 1993 |
| Grant date | Apr 23, 1996 |
| Priority date | — |
| Expiry date | Aug 3, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/0025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is the use of cloprostenol, fluprostenol, and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.